BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 21596168)

  • 1. [Impact of exacerbations on the clinical course of chronic obstructive pulmonary disease].
    Soler-Cataluña JJ; Martínez-García MA; Catalán Serra P; Román Sánchez P
    Rev Clin Esp; 2011 Mar; 211 Suppl 2():3-12. PubMed ID: 21596168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Multidimensional impact of COPD exacerbations].
    Soler-Cataluña JJ; Martínez-García MÁ; Serra PC
    Arch Bronconeumol; 2010 Dec; 46 Suppl 11():12-9. PubMed ID: 21316556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent chronic obstructive pulmonary disease exacerbators: how much real, how much fictitious?
    Soler-Cataluña JJ; Rodriguez-Roisin R
    COPD; 2010 Aug; 7(4):276-84. PubMed ID: 20673037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exacerbations of chronic obstructive pulmonary disease.
    Wedzicha JA; Donaldson GC
    Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cough and sputum production as risk factors for poor outcomes in patients with COPD.
    Miravitlles M
    Respir Med; 2011 Aug; 105(8):1118-28. PubMed ID: 21353517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Impact of exacerbations and admissions in chronic obstructive pulmonary disease].
    Arnedillo Muñoz A
    Arch Bronconeumol; 2010; 46 Suppl 8():8-14. PubMed ID: 21334550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of severe exacerbations on quality of life and the clinical course of chronic obstructive pulmonary disease.
    Niewoehner DE
    Am J Med; 2006 Oct; 119(10 Suppl 1):38-45. PubMed ID: 16996898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How should we define and classify exacerbations in chronic obstructive pulmonary disease?
    Trigueros Carrero JA
    Expert Rev Respir Med; 2013 Apr; 7(2 Suppl):33-41. PubMed ID: 23551022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COPD as a lung disease with systemic consequences--clinical impact, mechanisms, and potential for early intervention.
    Decramer M; Rennard S; Troosters T; Mapel DW; Giardino N; Mannino D; Wouters E; Sethi S; Cooper CB
    COPD; 2008 Aug; 5(4):235-56. PubMed ID: 18671149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practical management problems of chronic obstructive pulmonary disease in the elderly: acute exacerbations.
    Abbatecola AM; Fumagalli A; Bonardi D; Guffanti EE
    Curr Opin Pulm Med; 2011 Dec; 17 Suppl 1():S49-54. PubMed ID: 22209931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exacerbations and progression of disease in asthma and chronic obstructive pulmonary disease.
    Rennard SI; Farmer SG
    Proc Am Thorac Soc; 2004; 1(2):88-92. PubMed ID: 16113418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of clinical phenotypes of chronic obstructive pulmonary disease--a new treatment approach].
    Ter Arkh; 2011; 83(3):66-74. PubMed ID: 21675263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary care of the patient with chronic obstructive pulmonary disease-part 4: understanding the clinical manifestations of a progressive disease.
    Cooper CB; Dransfield M
    Am J Med; 2008 Jul; 121(7 Suppl):S33-45. PubMed ID: 18558106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of chronic obstructive pulmonary disease exacerbations on patients and payers.
    Wedzicha JA; Wilkinson T
    Proc Am Thorac Soc; 2006 May; 3(3):218-21. PubMed ID: 16636088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical phenotypes of COPD].
    Sobradillo P; García-Aymerich J; Agustí À
    Arch Bronconeumol; 2010 Dec; 46 Suppl 11():8-11. PubMed ID: 21316555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic markers of COPD. Role of comorbidity].
    Alvarez FV; Romero GP
    Arch Bronconeumol; 2009; 45 Suppl 4():2-7. PubMed ID: 20116742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of respiratory infection in exacerbation of chronic obstructive pulmonary disease].
    Dacydchenko SV; Bova AA
    Klin Med (Mosk); 2007; 85(5):10-5. PubMed ID: 17665597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New clinical parameters in chronic obstructive pulmonary disease].
    Izquierdo Alonso JL
    Arch Bronconeumol; 2008; 44 Suppl 2():4-10. PubMed ID: 19087838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical determinants of exacerbations in severe, early-onset COPD.
    Foreman MG; DeMeo DL; Hersh CP; Reilly JJ; Silverman EK
    Eur Respir J; 2007 Dec; 30(6):1124-30. PubMed ID: 17715170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Toward personalized and integrated treatment of patients with COPD].
    Ancochea J; Gómez García T; de Miguel Díez J
    Arch Bronconeumol; 2010 Dec; 46 Suppl 10():14-8. PubMed ID: 21316551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.